These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4318535)

  • 41. [Serotyping of recently isolated strains of Bordetella pertussis. II. Disparity of agglutination titers of patients' sera between antigens prepared from the Maeno and recently isolated strains (author's transl)].
    Sekiya K; Yamada M; Takamiya A; Nakase Y
    Nihon Saikingaku Zasshi; 1979 Nov; 34(6):827-35. PubMed ID: 231129
    [No Abstract]   [Full Text] [Related]  

  • 42. Potency testing of pertussis immunoglobulins, relationship between neutralisation test and agglutination test.
    Schneider W; Sabin S; Schwanig M
    Dev Biol Stand; 1979; 44():125-8. PubMed ID: 575633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antipertussis gamma globulins. IV. Isolation of immunoglobulins from mouse blood].
    Mitrică N; Andreescu V; Sorocinski F; Georgescu C; Caffé I; Marion M
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):471-6. PubMed ID: 4106079
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.
    Geurtsen J; Fae KC; van den Dobbelsteen GP
    Expert Rev Vaccines; 2014 Oct; 13(10):1229-40. PubMed ID: 25081731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Indices of the strength of collective pertussis immunity].
    Ryzhenko IM; Verezub LG; Vil'vovskaia RI; Tigraniants VN; Dubova ON
    Vrach Delo; 1981 Jul; (7):111-4. PubMed ID: 6269302
    [No Abstract]   [Full Text] [Related]  

  • 47. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serologic response and antibody-titer decay in adults with pertussis.
    Heininger U; Cherry JD; Stehr K
    Clin Infect Dis; 2004 Feb; 38(4):591-4. PubMed ID: 14765356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The presence of a substance complementary to the agglutinogen of B. pertussis in the serum of normal mice].
    Kuznetsov EA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):81-4. PubMed ID: 4337416
    [No Abstract]   [Full Text] [Related]  

  • 51. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 53. [The advantages and prospects of using immunoenzyme analysis for assessing pertussis immunity].
    Khardina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Jan; (1):65-8. PubMed ID: 1414112
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental development of immunity to pertussis].
    Kuznetsov EA; Shirko GN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):60-5. PubMed ID: 6250307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mouse or man? Which are pertussis vaccines to protect?
    Preston NW; Stanbridge TN
    J Hyg (Lond); 1976 Apr; 76(2):249-56. PubMed ID: 177701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 57. The pathology and immunology of Bordetella pertussis infection.
    Holt LB
    J Med Microbiol; 1972 Nov; 5(4):407-24. PubMed ID: 4345765
    [No Abstract]   [Full Text] [Related]  

  • 58. Whooping cough--aspects of pathogenesis and treatment.
    Trollfors B
    Acta Otolaryngol Suppl; 1984; 407():33-9. PubMed ID: 6093425
    [No Abstract]   [Full Text] [Related]  

  • 59. Antigenic structure and phase variation in Bordetella pertussis.
    Nakase Y; Takatsu K; Kasuga T
    Jpn J Microbiol; 1969 Sep; 13(3):283-91. PubMed ID: 4310290
    [No Abstract]   [Full Text] [Related]  

  • 60. The specificity of antisera against Bordetella pertussis examined by bacterial agglutination.
    Fredriksen JH; Frøholm LO; Kjennerud U
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):363-9. PubMed ID: 2894108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.